Search Results - "Bellenger, Katharine"

Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors by APPLETON, Kim, MACKAY, Helen J, TANG, Adrian, BELLENGER, Katharine, MACKAY, Lynsay, SETANOIANS, Albert, SCHÄTZLEIN, Andreas, TWELVES, Chris, KAYE, Stanley B, BROWN, Robert, JUDSON, Ian, PLUMB, Jane A, MCCORMICK, Carol, STRATHDEE, Gordon, LEE, Chooi, BARRETT, Sophie, READE, Sarah, JADAYEL, Dalal

“…The DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (decitabine) induces DNA demethylation and re-expression of epigenetically silenced genes, and…”
Get full text

Economic evaluation protocol of a short, all-oral bedaquiline-containing regimen for the treatment of rifampicin-resistant tuberculosis from the STREAM trial by Rosu, Laura, Madan, Jason, Worrall, Eve, Tomeny, Ewan, Squire, Bertel, Girma, Mamo, Patel, Vanita, Mukesh, Makwana, Muniyandi, Malaisamy, Kumar, Shravan, Subramani, Sangeetha, Ahmad, Saleem, Nidoi, Jasper, Pirlog, Irina, Macarie, Mariana, Rusen, ID, Bronson, Gay, Gurumurthy, Meera, Sanders, Karen, Meredith, Sarah, Nunn, Andrew, Ben Spittle, Wendy Dodds, Henry-Cockles, Robyn, Bennett, Rachel, Giallongo, Elisa, Maas, Danni, Goodall, Ruth, Ahmed, Saiam, Cook, Claire, Bellenger, Katharine, Narendran, Gopalan, Kirenga, Bruce, Tudor, Elena, Solanki, Rajesh, Meressa, Daniel, Bayissa, Adamu, Bhatnagar, Anuj

“…IntroductionA December 2019 WHO rapid communication recommended the use of 9-month all-oral regimens for treating multidrug-resistant tuberculosis (MDR-TB)…”
Get full text

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial by Goodall, Ruth L, Meredith, Sarah K, Nunn, Andrew J, Bayissa, Adamu, Bhatnagar, Anuj K, Bronson, Gay, Chiang, Chen-Yuan, Conradie, Francesca, Gurumurthy, Meera, Kirenga, Bruce, Kiria, Nana, Meressa, Daniel, Moodliar, Ronelle, Narendran, Gopalan, Ngubane, Nosipho, Rassool, Mohammed, Sanders, Karen, Solanki, Rajesh, Squire, S Bertel, Torrea, Gabriela, Tsogt, Bazarragchaa, Tudor, Elena, Van Deun, Armand, Rusen, I D, Adilaa, Oyunchimeg, Alexandru, Sofia, Bellenger, Katharine, Bennet, Jaclyn, Bennet, Deborah, Bindroo, Priyanka, Borisagar, Ghanshyam, Cook, Claire, Dalai, Doljinsuren, Davis, Andrew, de Jong, Bouke, Dodds, Wendy, Duckworth, Lynette, Gahima, Nonhlanhla, Gebreegziabher, Belay, Goldfeld, Anne, Hanifa, Mahmud, Hughes, Gareth, Kimuli, Ivan, Komrska, Jan, Lomtadze, Nino, Murphy, Brendan, Mwelase, Thando, Nalunjogi, Joanitah, Patel, Leena, Pirlog, Irina, Qawiy, Ishmael, Rauchenberger, Mary, Rigouts, Leen, Roach, Carol, Rosu, Laura, Santos-Filho, Ezio, Senguttuvan, Thirumaran, Sisay, Million, Sridhar, Rathinam, Srinivasulu, Vignes, Teferi, Mekonnen, Teklu, Helen, Tsegeen, Narangarav, van Amsterdam, Odette, White, Lisa, Whitney, Johanna, Zagd, Chuluunbaatar

“…The STREAM stage 1 trial showed that a 9-month regimen for the treatment of rifampicin-resistant tuberculosis was non-inferior to the 20-month 2011…”
Get full text

Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial by Goodall, Ruth L, Nunn, Andrew J, Meredith, Sarah K, Bayissa, Adamu, Bhatnagar, Anuj K, Chiang, Chen-Yuan, Conradie, Francesca, Gopalan, Narendran, Gurumurthy, Meera, Kirenga, Bruce, Kiria, Nana, Meressa, Daniel, Moodliar, Ronelle, Ngubane, Nosipho, Rassool, Mohammed, Sanders, Karen, Solanki, Rajesh, Squire, S Bertel, Teferi, Mekonnen, Torrea, Gabriela, Tsogt, Bazarragchaa, Tudor, Elena, Van Deun, Armand, Rusen, I D

“…STREAM stage 2 showed that two bedaquiline-containing regimens (a 9-month all-oral regimen and a 6-month regimen with 8 weeks of aminoglycoside) had superior…”
Get full text

Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis by Goodall, Ruth L, Sanders, Karen, Bronson, Gay, Gurumurthy, Meera, Torrea, Gabriela, Meredith, Sarah, Nunn, Andrew, Rusen, I D

“…Results from the STREAM stage 1 trial showed that a 9-month regimen for patients with rifampicin-resistant tuberculosis was non-inferior to the 20-month…”
Get full text

Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial by Rosu, Laura, Madan, Jason J, Tomeny, Ewan M, Muniyandi, Malaisamy, Nidoi, Jasper, Girma, Mamo, Vilc, Valentina, Bindroo, Priyanka, Dhandhukiya, Rajdeep, Bayissa, Adamu K, Meressa, Daniel, Narendran, Gopalan, Solanki, Rajesh, Bhatnagar, Anuj K, Tudor, Elena, Kirenga, Bruce, Meredith, Sarah K, Nunn, Andrew J, Bronson, Gay, Rusen, I D, Squire, S Bertel, Worrall, Eve, Ahmad, Saleem, Alexandru, Sofia, Bellenger, Katharine, Bulga, Tolera G., Cook, Claire, Crudu, Valeriu, Deborah, Bennet, Dodds, Wendy, Gebreegziabher, Belay A., Goodall, Ruth L., Gupta, Pritti, Gurumurthy, Meera, Langley, Ivor, Nalunjogi, Joanitah, Khan, Saleem, Krishnan, Saravanan, Kumar, Shravan, Lesosky, Maia, Macari, Mariana, Makwana, Mukesh, Murphy, Brendan, Murugesan, Ramesh P., Patel, Vanita, Pirlog, Irina, Rauchenberger, Mary, Sanders, Karen, Singh, Ramesh, Subramani, Sangeetha, Teferi, Mekonnen, Tegegn, Netsanet A., Velmurugan, Arun Babu, Whitney, Johanna

“…The STREAM stage 2 trial assessed two bedaquiline-containing regimens for rifampicin-resistant tuberculosis: a 9-month all-oral regimen and a 6-month regimen…”
Get full text